• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Tonix Pharmaceuticals Holding Corp

+ Add to Watchlist

TNXP:US

13.8200 USD 0.1700 1.22%

As of 16:30:00 ET on 08/20/2014.

Snapshot for Tonix Pharmaceuticals Holding Corp (TNXP)

Open: 13.9500 Day's Range: 13.8100 - 14.1500 Volume: 84,682
Previous Close: 13.9900 52wk Range: 3.0000 - 21.0000 1-Yr Rtn: +280.72%

Stock Chart for TNXP

No chart data available.
  • TNXP:US 13.8200
  • 1D
  • 1M
  • 1Y
13.9900
Interactive TNXP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TNXP

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -2.8000
Est. EPS (USD) (12/2014) -2.8100
Est. PEG Ratio -
Market Cap (M USD) 146.36
Shares Outstanding (M) 10.59
30 Day Average Volume 85,777
Price/Book (mrq) 2.8556
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TNXP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TNXP

Tonix Pharmaceuticals Holding Corp. is a pharmaceutical company that develops therapies for disorders of the central nervous system ("CNS"). The Company develops therapies for disorders that include fibromyalgia syndrome ("FM") and post-traumatic stress disorder ("PTSD"),

Seth LedermanChairman/President/CEO/FounderLeland J GershellCFO/Treasurer
Bruce L DaughertyChief Scientific OfficerGregory M SullivanChief Medical Officer
More Company Profile & Key Executives for TNXP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil